Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The yeast Pityrosporum ovale can cause skin allergies and infections, and antifungal treatments like ketoconazole are effective against it.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Organotypic culture systems can grow skin tissues that mimic real skin functions and are useful for skin disease and hair growth research, but they don't fully replicate skin complexity.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Regulatory T cells are essential for normal and improved wound healing in mice.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.